Search by Drug Name or NDC

    NDC 68180-0647-06 PAROXETINE 12.5 mg/1 Details

    PAROXETINE 12.5 mg/1

    PAROXETINE is a ORAL TABLET, FILM COATED, EXTENDED RELEASE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Lupin Pharmaceuticals, Inc.. The primary component is PAROXETINE HYDROCHLORIDE HEMIHYDRATE.

    Product Information

    NDC 68180-0647
    Product ID 68180-647_1a9bc25c-db83-42a0-851a-30212ee10cc6
    Associated GPIs 58160060007520
    GCN Sequence Number 050137
    GCN Sequence Number Description paroxetine HCl TAB ER 24H 12.5 MG ORAL
    HIC3 H2S
    HIC3 Description SELECTIVE SEROTONIN REUPTAKE INHIBITOR (SSRIS)
    GCN 17078
    HICL Sequence Number 007344
    HICL Sequence Number Description PAROXETINE HCL
    Brand/Generic Generic
    Proprietary Name PAROXETINE
    Proprietary Name Suffix n/a
    Non-Proprietary Name PAROXETINE
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET, FILM COATED, EXTENDED RELEASE
    Route ORAL
    Active Ingredient Strength 12.5
    Active Ingredient Units mg/1
    Substance Name PAROXETINE HYDROCHLORIDE HEMIHYDRATE
    Labeler Name Lupin Pharmaceuticals, Inc.
    Pharmaceutical Class Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA204134
    Listing Certified Through 2024-12-31

    Package

    NDC 68180-0647-06 (68180064706)

    NDC Package Code 68180-647-06
    Billing NDC 68180064706
    Package 30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (68180-647-06)
    Marketing Start Date 2017-03-06
    NDC Exclude Flag N
    Pricing Information
    Price Per Unit 0.63053
    Pricing Unit EA
    Effective Date 2024-02-21
    NDC Description PAROXETINE ER 12.5 MG TABLET
    Pharmacy Type Indicator C/I
    OTC N
    Explanation Code 1
    Classification for Rate Setting G
    As of Date 2024-02-21
    This pricing file, entitled the NADAC (National Average Drug Acquisition Cost) files, provide state Medicaid agencies with covered outpatient drug prices by averaging survey invoice prices from retail community pharmacies across the United States. These pharmacies include independent retail community pharmacies and chain pharmacies. The prices are updated on a weekly and monthly basis